Clinical trials
Community-acquired Pneumonia clinical trials
Below are recruiting community-acquired pneumonia clinical trials, each written for real people, not researchers. We’re tracking 32 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06114888Recruiting
New diagnostic tests for children hospitalized with pneumonia
This study tests new ways to diagnose pneumonia in children who are hospitalized. It aims to find the best methods to quickly identify the cause of pneumonia, so your child can get the right treatment sooner.
Hamilton, OntarioAges 6 months–18 years - NCT03795662Recruiting
Surviving Pneumonia
This trial studies treatment for pneumonia by enrolling people who have pneumonia signs on a chest X-ray plus typical symptoms like fever, cough, trouble breathing, or chest pain. It may help doctors test approaches for better outcomes after pneumonia.
HillerødAges 18 years+ - NCT02735707RecruitingPhase 3
Adaptive trial for severe pneumonia care in intensive care
This study tests ways to improve treatment for adults with severe pneumonia that lands them in the ICU, adjusting the plan as results come in. It may help your care team find better treatments for lung infection and breathing/heart support needs.
Jacksonville, FloridaAges 18 years+ - NCT07697885Recruiting
Lefamulin safety and effectiveness in pneumonia
This study watches how well the antibiotic lefamulin works in real-life patients with community-acquired pneumonia. It helps doctors understand the drug's safety and effectiveness outside of a controlled research setting.
Beijing, Beijing MunicipalityAges Any age - NCT07442656Recruiting
Frailty and outcomes in older adults with pneumonia
This study looks at how frailty (overall weakness and decline) affects recovery in older adults who come to the emergency room with pneumonia. The goal is to understand what outcomes patients can expect based on their frailty level.
Izmir, BornovaAges 65 years+ - NCT04647630Recruiting
Check which pneumococcus types cause pneumonia
This trial looks at which “pneumococcus” (a common germ) types are causing pneumonia in people admitted to the hospital. It uses a urine test kit to see how often different pneumococcal types are involved, which may help future treatment choices.
ShatinAges 18 years+ - NCT07359287Recruiting
Study on antibiotic use for respiratory infections
This study tests a program to help doctors prescribe antibiotics more carefully for common respiratory infections like colds, flu, bronchitis, and sinusitis. It may lead to better treatment for you.
CaenAges Any age - NCT05903352RecruitingPhase 3
Personalized antibiotic duration for hospital pneumonia patients
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
GarchesAges 18 years+ - NCT07278700Recruiting
Fever and respiratory infection study
This study looks at adults with a fever caused by a respiratory infection. If you qualify, you will have a blood draw as part of your regular care, and researchers will use it to learn more about your condition.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07164131RecruitingPhase 4
Comparing two antibiotics for hospitalized pneumonia patients
This trial compares two antibiotics, azithromycin and doxycycline, when given alongside a standard beta-lactam antibiotic to hospitalized adults with community-acquired pneumonia. It aims to see which combination works better and is safer.
Scottsdale, ArizonaAges 18 years+ - NCT03031210RecruitingPhase 2/Phase 3
Twice-daily amoxicillin for mild childhood pneumonia
This trial tests whether twice-daily amoxicillin helps treat non-severe pneumonia in children. It may be a good option if your child has a mild form confirmed by symptoms and a chest X-ray.
Montreal, QuebecAges 3 months–18 years - NCT07099976Recruiting
Better pneumonia treatment for kids in the ER
This trial tests a treatment plan for children with pneumonia who can be treated at home. It aims to find the best way to help kids get better faster and avoid complications.
Calgary, AlbertaAges 6 months–18 years - NCT07070284Enrolling by invitation
Severe pneumonia in older adults: a study of risks and outcomes
This study looks at older adults with severe pneumonia to understand what causes it and how to improve outcomes. If you are 65 or older and have severe pneumonia, this trial may help doctors learn more about your condition.
Zagreb, City of ZagrebAges 65 years+ - NCT07011433Enrolling by invitation
Pneumonia germs, inflammation, and recovery
This study looks at how certain parts of the bacteria that cause pneumonia (called virulence factors) and your body's natural inflammation markers are related to how well you recover. The goal is to learn more about what affects pneumonia outcomes, which could help doctors personalize treatment.
KaunasAges 18 years+ - NCT06996834Recruiting
Comparing breathing support methods for pneumonia-related breathing failure
This trial tests two noninvasive breathing support methods (NIV and HVNI) for people with pneumonia who are having trouble breathing. The goal is to see which method works better to help you avoid needing a breathing tube.
Asyut, AssuitAges 18 years+ - NCT06986148Recruiting
Comparing antibiotics for childhood pneumonia in clinics
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
Atlanta, GeorgiaAges 1 year–5.9 years - NCT06966310Recruiting
Awake prone positioning for community acquired pneumonia with high-flow oxygen
This trial tests whether lying on your stomach (prone position) while awake can help people with pneumonia breathe better and avoid needing a breathing tube. It is for patients in the ICU or step-down unit who need high-flow oxygen therapy.
AmiensAges 18 years+ - NCT06577558RecruitingPhase 2
SR1375 for severe pneumonia not improving on antibiotics
This trial tests a new drug called SR1375 for adults with severe community-acquired pneumonia (a lung infection) who are not improving with standard antibiotics. It may help reduce inflammation and speed up recovery.
Fuyang, AnhuiAges 18–85 - NCT06755814Recruiting
Registry for pneumonia in patients with weakened immune systems
This registry study collects information from patients hospitalized with pneumonia who also have a weakened immune system. The goal is to better understand how to treat and manage pneumonia in people like you.
Milan, MilanoAges 18 years+ - NCT06710080RecruitingPhase 3
Testing a medicine to reduce inflammation in pneumonia patients
This trial tests if a medicine called icosapent ethyl can reduce inflammation in blood vessels for adults hospitalized with pneumonia. It aims to see if this treatment can help prevent complications.
Ottawa, OntarioAges 18 years+ - NCT06670833Recruiting
Tools to improve childhood pneumonia care
This trial tests new tools to help doctors diagnose and manage pneumonia in children. It may help children with cough or trouble breathing who are not severely ill.
Dakar, DakarAges 2 months–12 years - NCT06295120RecruitingPhase 4
Finding the best antibiotic course for pneumonia in adults
This trial is testing how many days of antibiotics are best for adults with pneumonia who are treated by their regular doctor (not in a hospital). The goal is to find the shortest effective treatment to reduce side effects and antibiotic resistance.
GistrupAges 18 years+ - NCT06601998Recruiting
Heart health after severe pneumonia
This study looks at how heart health changes in people who have recovered from severe pneumonia, including COVID-19. It compares survivors to healthy people and those with heart risk factors.
AlexandroupoliAges 18 years+ - NCT06294600RecruitingPhase 3
Clarithromycin to prevent sepsis in pneumonia
This study tests whether the antibiotic clarithromycin can prevent pneumonia from getting worse and turning into sepsis. It is for adults with community-acquired pneumonia who have certain signs of infection in their blood.
Athens, AthensAges 18 years+
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Community-acquired Pneumonia trials by city
Studies with a site in or near these metro areas.
Common questions
- Are there clinical trials for community-acquired pneumonia?
- Yes. Clin2 currently lists 32 recruiting community-acquired pneumonia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a community-acquired pneumonia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a community-acquired pneumonia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.